Terms: = Breast cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Clinical Outcome
13 results:
1. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer.
Banys-Paluchowski M; Witzel I; Riethdorf S; Pantel K; Rack B; Janni W; Fasching PA; Aktas B; Kasimir-Bauer S; Hartkopf A; Solomayer EF; Fehm T; Müller V
Breast Cancer Res Treat; 2018 Nov; 172(1):93-104. PubMed ID: 30003393
[TBL] [Abstract] [Full Text] [Related]
2. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.
Banys-Paluchowski M; Fehm T; Janni W; Aktas B; Fasching PA; Kasimir-Bauer S; Milde-Langosch K; Pantel K; Rack B; Riethdorf S; Solomayer EF; Witzel I; Müller V
BMC Cancer; 2018 May; 18(1):541. PubMed ID: 29739347
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Eiro N; González L; Martínez-Ordoñez A; Fernandez-Garcia B; González LO; Cid S; Dominguez F; Perez-Fernandez R; Vizoso FJ
Cell Oncol (Dordr); 2018 Aug; 41(4):369-378. PubMed ID: 29497991
[TBL] [Abstract] [Full Text] [Related]
4. Impact of serum HER2, timp-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Ho D; Huang J; Chapman JW; Leitzel K; Ali SM; Shepherd L; Parulekar WR; Ellis CE; Crescnzo RJ; Zhu L; Virk S; Nomikos D; Aparicio S; Gelmon KA; Carney WP; Lipton A
Breast Cancer Res Treat; 2017 Aug; 164(3):571-580. PubMed ID: 28484925
[TBL] [Abstract] [Full Text] [Related]
5. The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer.
Szkandera J; Absenger G; Stotz M; Weissmueller M; Winder T; Langsenlehner T; Samonigg H; Renner W; Schippinger W; Gerger A
Anticancer Res; 2012 Aug; 32(8):3473-8. PubMed ID: 22843933
[TBL] [Abstract] [Full Text] [Related]
6. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract] [Full Text] [Related]
7. Expression of tissue inhibitor of matrix metalloproteinases (timp)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.
Mylona E; Magkou C; Giannopoulou I; Agrogiannis G; Markaki S; Keramopoulos A; Nakopoulou L
Breast Cancer Res; 2006; 8(5):R57. PubMed ID: 17032447
[TBL] [Abstract] [Full Text] [Related]
8. Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome.
Nakopoulou L; Mylona E; Papadaki I; Kavantzas N; Giannopoulou I; Markaki S; Keramopoulos A
Mod Pathol; 2006 Apr; 19(4):556-63. PubMed ID: 16474376
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract] [Full Text] [Related]
10. Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (timp-1) in breast carcinomas is correlated with adverse prognosis.
Nakopoulou L; Giannopoulou I; Stefanaki K; Panayotopoulou E; Tsirmpa I; Alexandrou P; Mavrommatis J; Katsarou S; Davaris P
J Pathol; 2002 Jul; 197(3):307-13. PubMed ID: 12115876
[TBL] [Abstract] [Full Text] [Related]
11. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (timp-1 and timp-2) in primary breast carcinomas are associated with development of distant metastases.
Ree AH; Florenes VA; Berg JP; Maelandsmo GM; Nesland JM; Fodstad O
Clin Cancer Res; 1997 Sep; 3(9):1623-8. PubMed ID: 9815852
[TBL] [Abstract] [Full Text] [Related]
12. Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
Zucker S; Lysik RM; DiMassimo BI; Zarrabi HM; Moll UM; Grimson R; Tickle SP; Docherty AJ
Cancer; 1995 Aug; 76(4):700-8. PubMed ID: 8625169
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced expression of tissue inhibitor of metalloproteinase-2 (timp-2) in the stroma of breast carcinomas correlates with tumor recurrence.
Visscher DW; Höyhtyä M; Ottosen SK; Liang CM; Sarkar FH; Crissman JD; Fridman R
Int J Cancer; 1994 Nov; 59(3):339-44. PubMed ID: 7927938
[TBL] [Abstract] [Full Text] [Related]
